![]() |
![]() |
| [ Ana Sayfa | Editörler | Danışma Kurulu | Dergi Hakkında | İçindekiler | Arşiv | Yayın Arama | Yazarlara Bilgi | E-Posta ] | |
| Fırat Üniversitesi Sağlık Bilimleri Veteriner Dergisi |
| 2025, Cilt 39, Sayı 3, Sayfa(lar) 147-153 |
| [ Turkish ] [ Tam Metin ] [ PDF ] |
| The Effect of Boric Acid on Uterine Ischemia-Reperfusion Injury in the Rats: A Histopathological Assessment |
| Mustafa Hilmi YARANOĞLU1, Zahid PAKSOY2, Nihat YUMUŞAK3 |
| 1Balıkesir University, Research Center for Experimental Animal Breeding, Balıkesir, TÜRKİYE 2Kahramanmaraş İstiklal University, Elbistan Vocationa School, Kahramanmaraş, TÜRKİYE 3Harran University, Veterinary Faculty, Department of Patology, Şanlıurfa, TÜRKİYE |
| Keywords: Boric acid, ischemia, reperfusion, rat |
|
The aim of this study was to investigate the protective effects of boric acid on uterine ischemia-reperfusion (IR) injury in rats. Twenty-four female rats were randomly divided into 3 groups. In the sham group, only laparotomy was performed. In the second group (IR), experimental ischemia (45 min) and reperfusion (1 hour) were induced. In the third group (BA+IR), boric acid was administered intraperitoneally at a dose of 200 mg/kg, 10 minutes before ischemia. Afterwards, uterine tissue was subjected to reperfusion for 1 hour. After the reperfusion period, the uterine tissues were surgically removed and fixed in formalin solution. Histopathological evaluation revealed significant differences in tissue damage among the groups (p<0.0001). The IR group exhibited marked edema, congestion, inflammation, necrosis and endometrial injury compared to the sham group (p<0.0001). In contrast, boric acid treatment significantly reduced these pathological changes. No significant histological difference was observed between sham and boric acid groups (p˃0.05). In conclusion, boric acid treatment demonstrated a protective effect against uterine IR injury and contributed to the preservation of endometrial health. These findings suggest its potential as a fertility-preserving agent in uterine ischemia.
|
| [ Turkish ] [ Tam Metin ] [ PDF ] |
![]() |
| [ Ana Sayfa | Editörler | Danışma Kurulu | Dergi Hakkında | İçindekiler | Arşiv | Yayın Arama | Yazarlara Bilgi | E-Posta ] |